Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gelber

Showing results (201-210 of 395) with videos related to

Pageof 40
Sort By:
BMC Medical Genomics|July 4, 2009
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trialChristine Desmedt, Anita Giobbie-Hurder, Patrick Neven, et al.
American Journal of Human Genetics|May 20, 1999
A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafnessM J Kovach, J P Lin, S Boyadjiev, et al.
Breast (Edinburgh, Scotland)|July 4, 2012
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancerSilvia Dellapasqua, Vincenzo Bagnardi, Meredith M Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Autologous bone marrow transplantation for acute lymphoblastic leukemiaS E Sallan, C M Niemeyer, A L Billett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2019
Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trialE M Holmes, I Bradbury, L S Williams, et al.
Breast (Edinburgh, Scotland)|June 15, 2020
Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trialZhuoxin Sun, Samuel M Niman, Olivia Pagani, et al.
BMJ (Clinical Research Ed.)|December 22, 2021
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysisFabio Conforti, Laura Pala, Isabella Sala, et al.
British Journal of Cancer|April 26, 2012
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancerK Ribi, J Aldridge, K-A Phillips, et al.
JAMA|July 4, 2002
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trialAlejandro Dorenbaum, Coleen K Cunningham, Richard D Gelber, et al.
The New England Journal of Medicine|August 21, 2009
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer, Henning Mouridsen, Anita Giobbie-Hurder, et al.
Pageof 40

Showing results (201-210 of 395) with videos related to

Sort By:
Pageof 40
BMC Medical Genomics|July 4, 2009
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trialChristine Desmedt, Anita Giobbie-Hurder, Patrick Neven, et al.
American Journal of Human Genetics|May 20, 1999
A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafnessM J Kovach, J P Lin, S Boyadjiev, et al.
Breast (Edinburgh, Scotland)|July 4, 2012
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancerSilvia Dellapasqua, Vincenzo Bagnardi, Meredith M Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Autologous bone marrow transplantation for acute lymphoblastic leukemiaS E Sallan, C M Niemeyer, A L Billett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2019
Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trialE M Holmes, I Bradbury, L S Williams, et al.
Breast (Edinburgh, Scotland)|June 15, 2020
Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trialZhuoxin Sun, Samuel M Niman, Olivia Pagani, et al.
BMJ (Clinical Research Ed.)|December 22, 2021
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysisFabio Conforti, Laura Pala, Isabella Sala, et al.
British Journal of Cancer|April 26, 2012
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancerK Ribi, J Aldridge, K-A Phillips, et al.
JAMA|July 4, 2002
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trialAlejandro Dorenbaum, Coleen K Cunningham, Richard D Gelber, et al.
The New England Journal of Medicine|August 21, 2009
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer, Henning Mouridsen, Anita Giobbie-Hurder, et al.
Pageof 40